Journal of Gastroenterology and Hepatology

Agent Orange: Your new look JGH (the improvements go deeper than the cover)
pp. 1167-1168(2)
Authors: Farrell, Geoffrey C; Desmond, Paul V; Wong, Benjamin C

Is the constipated Asian male more common than we think?
pp. 1168-1169(2)
Authors: Gwee, Kok-Ann; Wong, Reuben-K M

Cyclooxygenase-2 (COX-2): Does it matter in patients with HCV-related liver cirrhosis?
pp. 1169-1171(3)
Authors: Yu, Jun; Sung, Joseph JY

Growth factors as indicators of prognosis in liver failure
pp. 1171-1173(3)
Author: Shackel, Nicholas A

New frontiers in capsule endoscopy
pp. 1174-1177(4)
Authors: Fireman, Zvi; Kopelman, Yael

Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma
pp. 1178-1182(5)
Authors: Wu, Xiong-Zhi; Xie, Guang-Ru; Chen, Dan

Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome
pp. 1183-1189(7)
Authors: Harish, Kareem; Hazeena, Kizhekkan; Thomas, Varghese; Kumar, Sunil; Jose, Tony; Narayanan, Puthiyaveetil

Safety, tolerability and satisfaction with tegaserod therapy in Asia-Pacific patients with irritable bowel syndrome with constipation
pp. 1190-1198(9)
Authors: Fock, Kwong M; Wagner, Amy

High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease
pp. 1199-1204(6)
Authors: Fujimori, Shunji; Tatsuguchi, Atsushi; Gudis, Katya; Kishida, Teruyuki; Mitsui, Keigo; Ehara, Akihito; Kobayashi, Tsuyoshi; Sekita, Yoshihisa; Seo, Tsuguhiko; Sakamoto, Choitsu

Endoscopic management of traumatic hepatobiliary injuries
pp. 1205-1209(5)
Authors: Singh, Virendra; Narasimhan, Kannan Laksmi; Verma, Ganga Ram; Singh, Gurpreet

Endoscopic retrograde cholangiopancreatography in patients with Billroth II gastroenterostomy
pp. 1210-1213(4)
Authors: Çiçek, Bahattin; Parlak, Erkan; Dişibeyaz, Selçuk; Koksal, Aydın Seref; Şahin, Burhan

Validation of computer simulation training for esophagogastroduodenoscopy: Pilot study
pp. 1214-1219(6)
Author: Sedlack, Robert E

Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy
pp. 1220-1225(6)
Authors: Kim, Ji H; Yu, Sang K; Seo, Yeon S; Yim, Hyung J; Yeon, Jong E; Park, Jong J; Kim, Jae S; Bak, Young T; Lee, Chang H; Byun, Kwan S

Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?
pp. 1226-1231(6)
Authors: Cho, Soo-Jeong; Yoon, Jung-Hwan; Hwang, Seung-Sik; Lee, Hyo-Suk

Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: An Indian experience
pp. 1232-1235(4)
Authors: Mishra, Peeyush; Desai, Nutan; Alexander, Jacob; Singh, Dharmendra P; Sawant, Prabha

Hepatitis E in New Zealand
pp. 1236-1240(5)
Authors: Dalton, Harry R; Fellows, Helen J; Gane, Edward J; Wong, Philip; Gerred, Stephen; Schroeder, Bryan; Croxson, Margaret C; Garkavenko, Olga

Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis
pp. 1241-1248(8)
Authors: Schulte-Frohlinde, Ewert; Wagenpfeil, Stefan; Willis, Johanna; Lersch, Christian; Eckel, Florian; Schmid, Roland; Schusdziarra, Volker

Overexpressed cyclo-oxygenase-2 in the background liver is associated with the clinical course of hepatitis C virus-related cirrhosis patients after curative surgery for hepatocellular carcinoma
pp. 1249-1255(7)
Authors: Morinaga, Soichiro; Tarao, Kazuo; Yamamoto, Yuji; Nakamura, Yoshiyasu; Rino, Yasushi; Miyakawa, Kaoru; Ohkawa, Shinichi; Akaike, Makoto; Sugimasa, Yukio; Takemiya, Shoji

Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course
pp. 1256-1264(9)
Authors: Tacke, Frank; Trautwein, Christian; Yagmur, Eray; Hellerbrand, Claus; Wiest, Reiner; Brenner, David A; Schnabl, Bernd

Serum levels of stem cell factor and thrombopoietin are markedly decreased in fulminant hepatic failure patients with a poor prognosis
pp. 1265-1270(6)
Authors: Okumoto, Kazuo; Saito, Takafumi; Onodera, Motoyuki; Sakamoto, Ayuka; Tanaka, Mamiko; Hattori, Etsuko; Haga, Hiroaki; Ito, Jun-Itsu; Sugahara, Kazuhiko; Saito, Koji; Togashi, Hitoshi; Kawata, Sumio

Possible involvement of cytokine gene polymorphisms in fulminant hepatitis
pp. 1271-1277(7)
Authors: Takakura, Mihoko; Tokushige, Katsutoshi; Matsushita, Noriko; Hashimoto, Etsuko; Shiratori, Keiko

Antiviral action of interferon-α against hepatitis C virus replicon and its modulation by interferon-γ and interleukin-8
pp. 1278-1285(8)
Authors: Jia, Yintang; Wei, Lai; Jiang, Dong; Wang, Jianghua; Cong, Xu; Fei, Ran

Influence of cytochrome P450 2C19 genetic polymorphism and dosage of rabeprazole on accuracy of proton-pump inhibitor testing in Chinese patients with gastroesophageal reflux disease
pp. 1286-1292(7)
Authors: Lee, Yi-Chia; Lin, Jaw-Town; Wang, Hsiu-Po; Chiu, Han-Mo; Wu, Ming-Shiang

Inhibition of sympathetic pathways restores postoperative ileus in the upper and lower gastrointestinal tract
pp. 1293-1299(7)
Authors: Fukuda, Hiroyuki; Tsuchida, Daisuke; Koda, Keiji; Miyazaki, Masaru; Pappas, Theodore N; Takahashi, Toku

Effect of a gluten-free diet on growth and small-bowel histology in children with celiac disease in India
pp. 1300-1305(6)
Authors: Yachha, Surender K; Srivastava, Anshu; Mohindra, Samir; Krishnani, Narendra; Aggarwal, Rakesh; Saxena, Anita

Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease
pp. 1306-1312(7)
Authors: Gibson, Peter R; Weston, Adèle R; Shann, Amelia; Florin, Timothy H J; Lawrance, Ian C; Macrae, Finlay A; Radford-Smith, Graham

Changing incidence of acute pancreatitis: 10-year experience at the Royal Children's Hospital, Melbourne
pp. 1313-1316(4)
Authors: Nydegger, Andreas; Heine, Ralf G; Ranuh, Reza; Gegati-Levy, Ricardo; Crameri, Joe; Oliver, Mark R

Correlation between expression of leptin and clinicopathological features and prognosis in patients with gastric cancer
pp. 1317-1321(5)
Authors: Zhao, Xiaolong; Huang, Kaihong; Zhu, Zhaohua; Chen, Shuhong; Hu, Renming

Serum granulysin level as a novel prognostic marker in patients with gastric carcinoma
pp. 1322-1327(6)
Authors: Saigusa, Susumu; Ichikura, Takashi; Tsujimoto, Hironori; Sugasawa, Hidekazu; Majima, Takashi; Kawarabayashi, Nobuaki; Chochi, Kentaro; Ono, Satoshi; Kinoshita, Manabu; Seki, Shuhji; Ogawa, Kazuyuki; Mochizuki, Hidetaka

Effect of vasoactive intestinal peptide on gastric adenocarcinoma
pp. 1328-1335(8)
Authors: Li, Guo-Hua; Qian, Wei; Song, Geng-Qing; Hou, Xiao-Hua

Expression of MUC2 in gastric carcinomas and background mucosae
pp. 1336-1343(8)
Authors: Lee, Hae-Wan; Yang, Dae H; Kim, Hong K; Lee, Bong H; Choi, Kyung C; Choi, Young H; Park, Young E

Gastrointestinal: Buried bumper syndrome
pp. 1344-1344(1)

Hepatobiliary and pancreatic: Extended directional power Doppler ultrasonography in liver transplantation
pp. 1345-1345(1)

Gastrointestinal: Ileal ulcers induced by non-steroidal anti-inflammatory drugs
pp. 1346-1346(1)

Gastrointestinal: Peritoneal hydatidosis
pp. 1347-1347(1)

Hepatobiliary and pancreatic: Spontaneous cystogastric fistula
pp. 1348-1348(1)

Dieulafoy's disease as a possible cause of gallbladder hemorrhage
pp. 1349-1350(2)

The effect of Pseudomonas aeruginosa virulence factor, pyocyanin, on the liver sinusoidal endothelial cell
pp. 1350-1351(2)